DNAe will be attending the 32nd European Congress of Clinical Microbiology & Infectious Diseases, which will take place in Lisbon, Portugal. ECCMID, as the world’s premier Clinical Microbiology & Infectious Diseases event, brings together experts from many fields to present their latest findings, guidelines and experiences to an audience of over 14,000 colleagues.
Anglonordic is one of the premier conferences for European investors and R&D companies from the Nordics and the UK to connect with each other. With an established format of panel discussions, parallel technology and biotech investment rooms, plus 1:1 meetings, the conference returns as an in-person event this year.
DNAe will be attending the Scale Space Recruitment Fair, which is held where we are located. The Event will allow DNAe the opportunity to highlight our immediate graduate, internship opportunities to all Imperial College students.
The EACR Conference on Liquid Biopsies will provide a comprehensive overview of liquid biopsies in cancer. It will cover what is already in clinical practice, what is on the horizon for liquid biopsies in cancer patient management and the latest new techniques for high sensitivity profiling of solid tumours in the blood.
This London Tech Week, we will hear from those campaigning for and offering solutions to the DEI challenge in tech. Lynn Phillips, Global Head of HR at DNAe will be joining the panellists for a discussion on Monday, 13th of June, followed by a cocktail reception.
Hosted by One Nucleus, this one-day conference will address the main bio innovation trends, from the developments in life science and technology research to their translation into new diagnostics, prevention tools or treatments.
11.40AM Panel: Bio Innovation in Diagnostics – From Population to Precision
Alison Howie, VP Commercial at DNAe will join the panel discussion on how the technology developments in omics, biomarkers identification and data collection are shifting the value proposition for diagnostics.
The DNAe team will be attending the fourteenth annual Next Generation Dx Summit which will take place in-person on August 22-24. The Next Generation Dx Summit is the nexus for key opinion leaders across the world to share recent progress in diagnostic advancement and technology innovation. The event provides a valuable window on how point-of-care, infectious disease, liquid biopsy and companion diagnostics are changing the standard of care.
LSX hold events across the world focused on connecting life science and healthcare companies with the investors and partners they need to grow.
The DNAe team will be attending. Please contact firstname.lastname@example.org to set up a meeting.